Common Contracts
24 similar Research, Development and License Agreement contracts by Arqule Inc, Ligand Pharmaceuticals Inc, Signal Pharmaceuticals Inc, others
EXHIBIT 10.287 CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. AMENDED AND...Research, Development and License Agreement • January 13th, 2006 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
Exhibit 10.6.1 AMENDED AND RESTATED RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT This Agreement, effective as of January 1, 2001 (the "Effective Date"), is between ArQule, Inc. ("ArQule"), a Delaware corporation, and Solvay Pharmaceuticals B.V....Research, Development and License Agreement • March 12th, 2004 • Arqule Inc • Pharmaceutical preparations • England
EXHIBIT 10.234 FOURTH AMENDMENT TO AGREEMENT This Fourth Amendment to Agreement, effective September 9, 1999 is by and between AMERICAN HOME PRODUCTS CORPORATION ("AHP"), a Delaware corporation, as represented by its Wyeth-Ayerst Research Division,...Research, Development and License Agreement • May 7th, 2001 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.224 RESEARCH, DEVELOPMENT AND LICENSE AGREEMENTResearch, Development and License Agreement • August 14th, 2000 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10 RESEARCH, DEVELOPMENT AND LICENCE AGREEMENT DATED MAY 11, 1999 BETWEEN PRAXIS PHARMACEUTICALS, INC. AND FAIRCHILD INTERNATIONAL INC. RESEARCH, DEVELOPMENT AND LICENCE AGREEMENT DATED THE 11TH DAY OF MAY, 1999 BETWEEN: PRAXIS...Research, Development and License Agreement • July 20th, 2000 • Fairchild International Corp • Non-operating establishments • Australian Capital Territory
Exhibit 10.220 RESEARCH, DEVELOPMENT AND LICENSE AGREEMENTResearch, Development and License Agreement • May 15th, 2000 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
EXHIBIT 10.1Research, Development and License Agreement • April 5th, 2000 • Praxis Pharmaceuticals Inc/Cn • Pharmaceutical preparations • British Columbia
RECITALSResearch, Development and License Agreement • March 22nd, 2000 • Signal Pharmaceuticals Inc • Services-commercial physical & biological research • Massachusetts
RECITALSResearch, Development and License Agreement • February 18th, 2000 • Signal Pharmaceuticals Inc • Services-commercial physical & biological research • Massachusetts
ARES TRADING S.A. 2 RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT ------------------------------------------- TABLE OF CONTENTS -----------------Research, Development and License Agreement • February 18th, 2000 • Signal Pharmaceuticals Inc • Services-commercial physical & biological research • Massachusetts
RESEARCH, DEVELOPMENT AND LICENCE AGREEMENT DATED THE 11TH DAY OF MAY, 1999Research, Development and License Agreement • February 9th, 2000 • Fairchild International Corp • Non-operating establishments • British Columbia
EXHIBIT 10.1Research, Development and License Agreement • December 23rd, 1999 • Praxis Pharmaceuticals Inc/Cn • British Columbia
EXHIBIT 10.1 RESEARCH, DEVELOPMENT AND LICENSE AGREEMENTResearch, Development and License Agreement • November 15th, 1999 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
ARTICLE 1 DEFINITIONSResearch, Development, and License Agreement • August 14th, 1998 • Trega Biosciences Inc • Biological products, (no disgnostic substances) • Delaware
ARES TRADING S.A. 2 RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT ------------------------------------------- TABLE OF CONTENTS -----------------Research, Development and License Agreement • August 6th, 1998 • Signal Pharmaceuticals Inc • Services-commercial physical & biological research • Massachusetts
ARES TRADING S.A. 2 RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT ------------------------------------------- TABLE OF CONTENTS -----------------Research, Development and License Agreement • May 15th, 1998 • Signal Pharmaceuticals Inc • Massachusetts
EXHIBIT 10.21B [Abbott Diagnostics Division Letterhead] December 22, 1997 Mark Samuels President & CEO SpectRx, Inc. Dear Mark: This letter serves three purposes with respect to the ongoing Abbott/SpectRx research program for the extraction of...Research & Development and License Agreement • March 27th, 1998 • Spectrx Inc • Electromedical & electrotherapeutic apparatus
RECITALSResearch & Development and License Agreement • March 17th, 1998 • Arqule Inc • Pharmaceutical preparations • Illinois
CERTAIN CONFIDENTIAL MATERIAL CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. SECOND AMENDMENT...Research, Development and License Agreement • August 14th, 1997 • Cortech Inc • Pharmaceutical preparations
RECITALSResearch & Development and License Agreement • March 7th, 1997 • Arqule Inc • Pharmaceutical preparations • Illinois
ANDResearch & Development and License Agreement • February 27th, 1997 • Spectrx Inc • Delaware
RECITALSResearch & Development and License Agreement • October 16th, 1996 • Arqule Inc • Pharmaceutical preparations • Illinois
RECITALSResearch & Development and License Agreement • October 15th, 1996 • Arqule Inc • Pharmaceutical preparations • Illinois
1 Exhibit 10.14 ------------- RESEARCH, DEVELOPMENT AND LICENSE AGREEMENTResearch, Development and License Agreement • October 15th, 1996 • Arqule Inc • Pharmaceutical preparations • England
